SME Times is powered by   
Search News
Just in:   • Markets end on flat note, RIL hits new high  • Exports contract over 12% in June  • RBI likely to cut rates on growth concerns  • Drastic arrest in the decline of exports: FIEO  • SBI Board approves raising of up to Rs 25K cr via bonds 
Last updated: 05 Jun, 2015  

Cadila Initiates 'Consume With Care' Awareness Drive

NewsVoir | 04 Jun, 2015

With an aim to increase awareness on environmental issues and the citizen’s responsibilities towards it, Ahmedabad based Cadila Pharmaceuticals Ltd is going to celebrate ‘World Environment Day’ in a unique way. The Company will launch ‘Consume with Care and Sustainable Production’ awareness drive to conserve natural resources that are fast depleting. Other activities like poster competition, essay contest, quiz and slogan contest, based on the theme of ‘Sustainability and Consumption’ will also be organized at company’s various locations. 

 

Consume with Care, fosters awareness about saving paper, electricity, water, less usage of plastic and recycling of electronic devices. On the Environment day, employees will also sign a pledge to commit themselves to save the environment through conscious and careful consumption in their day today lives. 

 

As a part of this awareness drive, the company has designed a teaser campaign that conveys ways in which the employees can save wastage of precious natural resources. Through the campaign, the company intends to drive home the point and motivate its employees to be a responsible citizen. Just a simple conscious act by each individual at Cadila Pharmaceuticals, will contribute in doing their bit for the environment and thereby saving on trees, water and reducing CO2 emissions.

 

The company is also organizing a plantation drive and ‘No Food Wastage’ campaign. Besides their Corporate Campus at Bhat, Ahmedabad, these activities will also be organized at Ankleshwar, Dholka and Jammu manufacturing facilities of the company.

 

About Cadila Pharmaceuticals Limited - www.cadilapharma.com

Cadila Pharmaceuticals is one of the largest privately held pharmaceuticals companies in India, headquartered at Ahmedabad, Gujarat, India. Established in 1951, the company develops and manufactures pharmaceutical products and sells and distributes these in all major markets across the globe. It is an integrated healthcare solutions provider with a comprehensive therapeutic basket including oncology, pulmonology, neurology and cardiovascular.

 

In line with the vision of its Founder Chairman, Mr. I. A. Modi, who believed in nurturing innovations and bringing them to Indian patients at an affordable cost, Cadila Pharmaceuticals has a track record of making available, many first-in-the-world innovative products like Polycap (5 in 1 pill for prevention and treatment of cardiovascular diseases), Risorine (Innovative solution for treatment of Tuberculosis) and most recently introduced Mycidac-C, which is the world's first active immunotherapy in lung cancer.

 

Cadila Pharmaceuticals has collaborations with premier academic and research-based organizations across the world.

 

Cadila Pharmaceuticals was the first Indian company to get IND approval by USFDA for clinical trials to be conducted in India. Subsequently, the company has filed 5 INDs with the USFDA. 

 
Print the Page Add to Favorite
 
Share this on :
 

Please comment on this story:
 
Subject :
Message:
(Maximum 1500 characters)  Characters left 1500
Your name:
 

 
  Customs Exchange Rates
Currency Import Export
US Dollar
66.20
64.50
UK Pound
87.50
84.65
Euro
78.25
75.65
Japanese Yen 58.85 56.85
As on 15 Jul, 2020
  Daily Poll
COVID-19 has directly affected your business
 Yes
 No
 Can't say
  Commented Stories
» Covid-19 Essentials Expo India(2)
» Starting an import export business: Basic guide for beginners(1)
» Subsidy provided to artisans under Solar Charkha Mission: MSME minister(1)
» Pain points for MSMEs(1)
» China's forex reserves reach USD 2.85 trillion(1)
 
 
About Us  |   Advertise with Us  
  Useful Links  |   Terms and Conditions  |   Disclaimer  |   Contact Us  
Follow Us : Facebook Twitter